Financhill
Back

Verrica Pharmaceuticals Vs. Corcept Therapeutics Industry Stock Comparison

Sell
29

VRCA
Verrica Pharmaceuticals

Last Price:
$0.48
Seasonality Move:
-11.93%
Sell
46

CORT
Corcept Therapeutics

Last Price:
$68.59
Seasonality Move:
2.94%
Sell
29
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals [VRCA] share price is $0.48. The Score for VRCA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Corcept Therapeutics (CORT) is a Sell

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $68.62. The Score for CORT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals's stock price today?

  • The Verrica Pharmaceuticals share price today is $0.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $68.62
    The current trend is moderately bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 45.48 Sell
Chaikin Money Flow: 185445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.45 - 0.61) Sell
Bollinger Bands (100): (0.53 - 0.89) Sell

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.73 Buy
Relative Strength Index (14 RSI): 50.15 Buy
Chaikin Money Flow: 963031 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.81 - 80.17) Buy
Bollinger Bands (100): (51.04 - 70.1) Buy

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.5 Sell
20-day SMA: 0.51 Sell
50-day SMA: 0.6 Sell
200-day SMA: 2.21 Sell
8-day EMA: 0.49 Sell
20-day EMA: 0.52 Sell
50-day EMA: 0.61 Sell
200-day EMA: 1.98 Sell

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.01 Sell
20-day SMA: 68.65 Sell
50-day SMA: 65.66 Buy
200-day SMA: 49.93 Buy
8-day EMA: 71.22 Sell
20-day EMA: 59.16 Buy
50-day EMA: 35.29 Buy
200-day EMA: 11.08 Buy

Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.12 per share.

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.

Verrica Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):